GlassScriptPhysician profile
Sarah Allan
NPI 1245871623
$1,337.46
in general payments reported to CMS, 2019-2025
18 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $268 · 2023: $466 · 2024: $202 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $290.72 | 2022-2025 | |
| Amgen INC. | $228.63 | 2023-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $223.28 | 2024-2025 | |
| Genzyme Corporation | $99.18 | 2021-2025 | |
| Galderma Laboratories, L.P. | $76.86 | 2022-2025 | Nemluvio |
| Kyowa Kirin, INC. | $59.33 | 2021-2022 | |
| Pfizer INC. | $56.48 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $53.35 | 2025 | Sotyktu |
| Organogenesis INC. | $40.93 | 2021 | |
| Ucb, INC. | $37.09 | 2021-2023 | Bimzelx |
| Krystal Biotech INC | $34.23 | 2024 | Vyjuvek |
| Regeneron Healthcare Solutions, INC. | $25.62 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.87 | 2025 | Cabtreo |
| Dermavant Sciences, INC. | $19.59 | 2024 | Vtama |
| Lilly USA, LLC | $19.26 | 2025 | Ebglyss, Taltz |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $18.61 | 2024 | |
| Helsinn Therapeutics (U.S.), INC. | $16.31 | 2022 | |
| Incyte Corporation | $16.12 | 2024 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Allan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.